Xencor Inc is a healthcare company based in the United States. As a pharmaceutical manufacturer, it lays emphasis on addressing severe diseases including allergy and cancer. It uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. Xencor earns its revenue from research and development collaborations and licenses of its internally-developed drug candidates.